| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $284.9M | +13.0% |
| Cost of Revenue | $107.3M | +8.5% |
| Gross Profit | $177.6M | +15.9% |
| R&D Expense | $11.4M | +3.3% |
| SG&A Expense | $79.0M | +18.2% |
| Operating Income | -$119.1M | -162.5% |
| Pre-tax Income | -$129.4M | -92.0% |
| Income Tax | -$12.5M | -30.2% |
| Net Income | -$116.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $276.0M | +2458.0% |
| Short-term Investments | $77.7M | — |
| Accounts Receivable | $79.0M | +98.4% |
| Current Assets | $455.6M | +173.8% |
| Total Assets | $2.27B | +144.4% |
| Current Liabilities | $535.3M | -10.0% |
| Long-term Debt | $417.0M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.9M | -418.6% |
| Capital Expenditures | $420K | -83.8% |
| Investing Cash Flow | -$79.4M | -38.8% |
| Financing Cash Flow | $409.6M | +457.9% |
| Free Cash Flow | -$65.3M | -332.4% |
| -102.3% |
| EPS (Basic) | -$2.65 | -90.6% |
| EPS (Diluted) | -$2.65 | -90.6% |
| Total Liabilities |
| $694.6M |
| -29.3% |
| Stockholders' Equity | $1.57B | +2992.9% |